FDA Brief

Warning letters Drugs

FDA warning letter to

Seatex, LLC

High riskIssued Apr 1, 2024Posted May 14, 2024Division of Pharmaceutical Quality Operations II

Seatex, LLC made OTC hand sanitizer drugs with inadequate current good manufacturing practice (CGMP), including shared equipment with industrial chemicals and missing component testing.

What happened

FDA inspected Seatex's drug manufacturing facility in Rosenberg, Texas, from October 16 to October 20, 2023. FDA found OTC hand sanitizer made on equipment also used for non-pharmaceutical products such as floor cleaner without cleaning validation, inadequate investigations and records for failing test results, and no identity testing or methanol, diethylene glycol (DEG), or ethylene glycol (EG) limits for incoming ethanol and glycerin. After a February 8, 2024 teleconference, the company recalled four products on February 19, 2024; FDA found the November 3, 2023 response inadequate.

What FDA found

  1. Made OTC hand sanitizer on equipment also used for industrial chemicals such as floor cleaner without cleaning validation studies.

    21 CFR 211.67(b)
  2. Failed to properly investigate out-of-specification test results and did not record or retain failing results.

    21 CFR 211.192
  3. Did not perform identity testing for incoming components such as ethanol and glycerin, and did not test ethanol for methanol or glycerin for diethylene glycol (DEG) or ethylene glycol (EG).

    21 CFR 211.84(d)(1) and 211.84(d)(2)
  4. Quality control unit lacked authority and records to ensure CGMP compliance, including missing equipment, water system, and process validation records.

    21 CFR 211.22

What FDA wants

Respond in writing within 15 working days with what you have done to correct violations and prevent recurrence, and clarify whether you intend to resume drug manufacturing and notify FDA before doing so.

Who should pay attention

  • manufacturers of OTC hand sanitizers
  • companies sharing equipment between drugs and industrial products
  • drugmakers relying on supplier certificates for ethanol or glycerin

This is a summary. Read the original letter on fda.gov.

Seatex, LLC's FDA history

  1. Seatex, LLC

    FDA: Seatex made hand sanitizer on equipment also used for floor cleaner and skipped ingredient identity tests.

    High risk

Full company page

Similar letters to other companies

  1. Baxter International Inc.

    Baxter's Round Lake injectable drug plant violated CGMP (manufacturing quality rules), with cephalosporin cross-contamination and sterile processing failures.

    High risk
  2. Signature Formulations LLC

    FDA warns Signature Formulations about contaminated contract-manufactured drug products and cross-contamination at its Phoenix facility.

    High risk
  3. Shoolin Pharma Chem LLP

    Shoolin Pharma Chem, an Indian API maker, warned over filthy conditions, missing test data, and cleaning failures; all U.S. APIs recalled.

    High risk
  4. Dabur India Limited

    FDA cites Dabur India for falsified records, incomplete lab data, and inadequate cleaning and process validation for over-the-counter drugs.

    High risk